GLP-1 medications mimic this hormone resulting in lower blood sugar , reduced appetite, and slower digestion of food
glucose monitoring, weight, tracking physical activity) in clinical visits to convey their importance in achieving the desired health behaviour goals
The multifaceted nature of overweight and obesity intertwines with various comorbidities, including cardiovascular diseases, type 2 diabetes mellitus (T2DM), musculoskeletal disorders, and certain cancers, thereby underscoring the imperative for effective management strategies [2]
When cells in the thyroid grow abnormally, they can form nodules
La tirzepatida es un medicamento inyectable aprobado por la FDA para el tratamiento de la diabetes tipo 2 (bajo el nombre comercial Mounjaro) y para el manejo del peso en adultos con obesidad (IMC 30 kg/m) o sobrepeso (IMC 27 kg/m) con al menos una comorbilidad relacionada con el peso (como Zepbound)